GaurabChakrabartiMD

PubMed

• 4 citations
  Hydrogen peroxide inhibition of bicupin oxalate oxidase.
  John Goodwin, Hassan Rana, Joan Ndungu, Gaurab Chakrabarti, Ellen W. Moomaw> ;Plos One. 2017 May 9
• 83 citations
  Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors.
  Xiumei Huang, Edward A. Motea, Zachary R. Moore, Jun Yao, Ying Dong, Gaurab Chakrabarti, Jessica A. Kilgore, Molly A. Silvers, Praveen L. Patidar, Agnieszka Cholka, Fa...> ;Cancer Cell. 2016 Dec 12
• 8 citations
  Using DNA devices to track anticancer drug activity.
  Dimithree Kahanda, Gaurab Chakrabarti, Marc A. McWilliams, David A. Boothman, Jason D. Slinker> ;Biosensors & Bioelectronics. 2016 Jun 15
• 39 citations
  NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer.
  Long Shan Li, Srilakshmi Reddy, Zhen Hua Lin, Shuangping Liu, Hyunsil Park, Stephen G. Chun, William G. Bornmann, Joel Thibodeaux, Jingsheng Yan, Gaurab Chakrabarti, X...> ;Molecular Cancer Therapeutics. 2016 Jan 1
• 37 citations
  Depleting Tumor-NQO1 Potentiates Anoikis and Inhibits Growth of NSCLC
  Brian Madajewski, Michael A. Boatman, Gaurab Chakrabarti, David A. Boothman, Erik A. Bey> ;Molecular Cancer Research. 2016 Jan 1
• 46 citations
  Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone
  Gaurab Chakrabarti, Molly A. Silvers, Mariya Ilcheva, Yuliang Liu, Zachary R. Moore, Xiuquan Luo, Jinming Gao, Glenda G. Anderson, Lili Liu, Venetia R. Sarode, David E...> ;Scientific Reports. 2015 Nov 25
• 93 citations
  Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone.
  Gaurab Chakrabarti, Zachary R. Moore, Xiuquan Luo, Mariya Ilcheva, Aktar Ali, Mahesh S. Padanad, Yunyun Zhou, Yang Xie, Sandeep Burma, Pier Paolo Scaglioni, Lewis C. C...> ;Cancer & Metabolism. 2015 Oct 12
• 43 citations
  Mutant KRAS associated malic enzyme 1 expression is a predictive marker for radiation therapy response in non-small cell lung cancer
  Gaurab Chakrabarti> ;Radiation Oncology. 2015 Jul 16
• 13 citations
  Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways
  Gaurab Chakrabarti, David E. Gerber, David A. Boothman> ;Clinical Pharmacology. 2015 Mar 27
• 66 citations
  NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone.
  Zachary R. Moore, Gaurab Chakrabarti, Xiang Luo, Aktar Ali, Zeping Hu, Farjana J. Fattah, R. Vemireddy, Ralph J. DeBerardinis, Rolf A. Brekken, David A. Boothman> ;Cell Death & Disease. 2015 Jan 1
• 30 citations
  Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers.
  Lifen Cao, Long Shan Li, Christopher Spruell, Ling Xiao, Gaurab Chakrabarti, Erik A. Bey, Kathryn E. Reinicke, Melissa C. Srougi, Zachary R. Moore, Ying Dong, Peggy Vo...> ;Antioxidants & Redox Signaling. 2014 Jul 10
• 49 citations
  What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up.
  Anna Buteau, Casey A. Seideman, Robert S. Svatek, Ramy F. Youssef, Gaurab Chakrabarti, Gary Reed, Deepa Bhat, Yair Lotan> ;Urologic Oncology. 2014 Feb 1
• Join now to see all